METTL14 reduces the degradation of PD-L1 via the ubiquitination-dependent pathway by destabilizing Siah2 mRNA in a YTHDF2-dependent manner in cholangiocarcinoma (CCA).107. Here, METTL14 is linked to cholangiocarcinoma.